Steven Pieper

Insider Reports History

Entity
Individual
Location
Xeris Pharmaceuticals, Inc., 180 N. Lasalle Street, Suite 1600, Chicago, IL
Signature
/s/ Beth Hecht, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Pieper:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Chief Financial Officer Common Stock 1.42M $3.71M $2.61 Jul 28, 2024 Direct
XERIS PHARMACEUTICALS INC Chief Financial Officer Common Stock 0 Oct 5, 2021 Direct
XERIS PHARMACEUTICALS INC Chief Financial Officer Stock Option (Right to Buy) 0 Oct 5, 2021 Direct

Insider Reports Filed by Steven Pieper

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XERS Xeris Biopharma Holdings, Inc. Jan 31, 2024 1 $0 4 Jan 31, 2024 Chief Financial Officer
XERS Xeris Biopharma Holdings, Inc. Nov 20, 2023 1 $54.6K 4 Nov 21, 2023 Chief Financial Officer
XERS Xeris Biopharma Holdings, Inc. Jan 31, 2023 1 $0 4 Feb 1, 2023 Chief Financial Officer
XERS Xeris Biopharma Holdings, Inc. Jan 29, 2022 11 -$454K 4 Aug 9, 2024 Chief Financial Officer
XERS Xeris Biopharma Holdings, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Financial Officer
XERS Xeris Biopharma Holdings, Inc. Nov 10, 2021 1 $49.9K 4 Nov 12, 2021 Chief Financial Officer
XERS Xeris Biopharma Holdings, Inc. Oct 5, 2021 7 $0 4 Oct 5, 2021 Chief Financial Officer
XERS XERIS PHARMACEUTICALS INC Oct 5, 2021 7 $0 4 Oct 5, 2021 Chief Financial Officer
XERS Xeris Biopharma Holdings, Inc. Oct 5, 2021 0 $0 3 Oct 5, 2021 Chief Financial Officer
XERS XERIS PHARMACEUTICALS INC Jul 28, 2021 1 $0 4 Jul 29, 2021 Chief Financial Officer
XERS XERIS PHARMACEUTICALS INC Jul 28, 2021 0 $0 3 Jul 29, 2021 Senior Vice President, General Counsel and Corporate Secretary Exhibit 24.1: Power of Attorney attached